MedDeviceGuideMedDeviceGuide
Back

Medical Device Regulatory Consulting Hourly Rates by Region (2026)

Benchmark medical device regulatory consulting rates by region and consultant tier, with cost drivers and budgeting guidance for registration projects in major markets.

Ran Chen
Ran Chen
Global MedTech Expert | 10× MedTech Global Access
Published 2026-04-07Last reviewed 2026-04-0710 min read

Why Consulting Rates Matter for Your Regulatory Budget

Medical device regulatory consulting is a specialized field where expertise directly impacts whether your device reaches the market — and how fast. Unlike many professional services, regulatory consulting rates vary dramatically by geography, consultant experience level, and the complexity of your regulatory pathway.

This guide provides transparent, current rate benchmarks to help you budget accurately and evaluate proposals. We compiled this data from published fee schedules, industry reports, and market analysis across the major medical device markets.

How Consultant Tiers Work

Most regulatory consulting firms structure their billing around three tiers:

TierTypical RoleExperienceRate Range
Tier 1Senior strategist, project lead, former FDA/NB reviewer15+ years, deep specializationHighest
Tier 2Regulatory specialist, submission author5–15 years, broad expertiseMid-range
Tier 3Associate, documentation support, research analyst2–5 years, supervised workLowest

For complex projects (PMA, De Novo, novel technology), you need Tier 1 and Tier 2 resources. For straightforward 510(k) submissions with well-established predicates, Tier 2 and Tier 3 resources may be sufficient.

Hourly Rate Benchmarks by Region (2025–2026)

North America

CountryAuthorityTier 1 ($/hr)Tier 2 ($/hr)Tier 3 ($/hr)Notes
United StatesFDA$375–$450$275–$325$150–$200Premium for complex pathways (PMA, De Novo, Breakthrough)
CanadaHealth Canada$330–$395$245–$295$135–$180Class II–IV licensing complexity affects rates

Europe

Country/RegionAuthorityTier 1 ($/hr)Tier 2 ($/hr)Tier 3 ($/hr)Notes
European UnionNotified Bodies / Competent Authorities$350–$425$260–$315$140–$185Rates vary by member state; EU MDR compliance driving demand
United KingdomMHRA$340–$400$250–$300$135–$175UKCA pathway post-Brexit adds complexity
SwitzerlandSwissmedic$345–$410$255–$305$140–$180Mirrors EU MDR with national application

Asia-Pacific

CountryAuthorityTier 1 ($/hr)Tier 2 ($/hr)Tier 3 ($/hr)Notes
JapanPMDA$360–$430$265–$320$145–$190Premium for mandatory PMDA consultations and Japanese translation
ChinaNMPA$335–$395$250–$300$135–$180Clinical trial oversight and translations add to costs
South KoreaMFDS$330–$390$245–$295$130–$175KGMP audit preparation is a significant service line
IndiaCDSCO$290–$340$210–$260$110–$150Local liaison fees may be included
AustraliaTGA$325–$385$240–$290$130–$175Streamlined but specific processes

Middle East

CountryAuthorityTier 1 ($/hr)Tier 2 ($/hr)Tier 3 ($/hr)Notes
Saudi ArabiaSFDA$320–$380$240–$290$130–$170Premium for mandatory audit support
UAEMOHAP / DHA$310–$370$230–$280$125–$165Multiple emirate coordination; MOHAP, DHA, and DOH

Latin America

CountryAuthorityTier 1 ($/hr)Tier 2 ($/hr)Tier 3 ($/hr)Notes
BrazilANVISA$315–$375$235–$285$125–$170Complex and lengthy approval process
MexicoCOFEPRIS$305–$355$225–$275$120–$160Requires local representation
Recommended Reading
Pure Global AI: A Practical Workflow Guide for Medical Device Regulatory Teams
RegulatoryDigital Health & AI2026-08-10 · 21 min read

What Drives Consulting Costs Beyond Hourly Rates

Hourly rates alone don't tell the full cost story. Several factors influence total project costs:

Regulatory Pathway Complexity

PathwayTypical Consultant HoursTypical Total CostKey Cost Drivers
510(k) — straightforward80–200 hours$17,500–$50,000Predicate research, testing plan, submission authoring
510(k) — complex200–400 hours$50,000–$120,000Clinical data, multiple predicates, software/AI components
De Novo300–600 hours$75,000–$200,000Novel classification, clinical evidence, benefit-risk analysis
PMA800–2,000+ hours$200,000–$1,000,000+Clinical trials, advisory panel preparation, extensive data
EU MDR CE Marking (Class IIa)150–300 hours$30,000–$80,000Technical file, clinical evaluation, NB interaction
EU MDR CE Marking (Class III)400–800+ hours$100,000–$300,000+Clinical data, extensive CER, NB audit preparation

Additional Cost Factors

Translation requirements are a significant budget item for markets like Japan (all documents must be in Japanese), China (NMPA submissions in Mandarin), South Korea (MFDS submissions in Korean), and most LATAM markets (Spanish or Portuguese). Translation costs typically run $0.15–$0.30 per word for technical regulatory documents.

Local representative fees are required in most markets outside the US. These are typically annual retainers rather than hourly rates:

CountryLocal Rep/Agent Annual FeeNotes
EU (EC Rep)$3,000–$10,000/yearRequired for non-EU manufacturers
UK (UKRP)$3,000–$8,000/yearRequired post-Brexit
Japan (DMAH/MAH)$20,000–$80,000/yearMost expensive; holds product license
South Korea (KLH)$10,000–$30,000/yearIdentical product license option available
China (Legal Agent)$5,000–$15,000/yearRequired for NMPA registration
India (IAA)$3,000–$8,000/yearIndian Authorized Agent
Saudi Arabia (AR)$5,000–$15,000/yearAuthorized Representative license mandatory
Brazil (BRH)$8,000–$20,000/yearBrazil Registration Holder

Testing costs are often the largest single budget item and are separate from consulting fees:

Test CategoryTypical Cost Range
Biocompatibility (ISO 10993 suite)$10,000–$50,000
Electrical safety & EMC$5,000–$30,000
Software validation & verification$10,000–$50,000
Clinical studies$50,000–$500,000+
Cybersecurity testing$10,000–$40,000
Sterilization validation$5,000–$25,000

Regional Market Size and Demand for Regulatory Consulting

The global medical device regulatory affairs market is experiencing significant growth, driven by regulatory complexity across all major markets:

  • North America accounts for approximately 42% of global regulatory consulting spending, driven by the FDA's 3,000+ annual 510(k) clearances and expanding cybersecurity requirements

  • Europe is a heavy spender due to the phased rollout of EU MDR, IVDR, and EUDAMED's mandatory use beginning May 2026

  • Asia-Pacific is the fastest-growing region, with reforms in China and India halving or reducing review times, enticing more manufacturers to file in these markets

How to Evaluate a Regulatory Consulting Proposal

When comparing proposals from regulatory consulting firms, look beyond the hourly rate:

Key Questions to Ask

  1. What tier(s) of consultant will work on my project? Make sure the proposal specifies who does what — a $400/hr senior strategist guiding strategy and a $175/hr associate writing the submission may be more cost-effective than a mid-tier consultant doing everything.

  2. Is the estimate fixed-fee or time-and-materials? Fixed-fee proposals provide budget certainty but may exclude scope changes. Time-and-materials proposals are more flexible but require careful project management.

  3. What is included and excluded? Common exclusions include FDA user fees, testing costs, translation, local representative fees, and travel expenses. Make sure you understand the full cost picture.

  4. What is the firm's track record with my type of device? Ask for specific experience with your device classification, regulatory pathway, and target market. A firm with relevant experience will be more efficient than one learning your space.

  5. What happens if the submission receives an AI request or RTA hold? Understand how additional work is scoped and billed. Some firms include one round of AI response in their base fee; others bill separately.

Red Flags in Proposals

  • Vague scope definitions — If the proposal doesn't clearly define deliverables, milestones, and assumptions, the final cost will likely exceed the estimate

  • Unrealistically low fees — A 510(k) proposal for $5,000 likely means the firm plans to use junior staff with minimal supervision or is underestimating the work

  • No mention of your specific device type — Generic proposals suggest the firm hasn't invested time in understanding your product

  • Guaranteed clearance claims — No reputable firm can guarantee FDA clearance. Claims of "100% success rate" should be scrutinized

Recommended Reading
EClinCloud EDC for Device Studies: Linking Versions, Deficiencies and Endpoints
Clinical EvidenceRegulatory2026-09-07 · 35 min read

Common Engagement Models

ModelHow It WorksBest ForTypical Fee Structure
Project-basedFixed scope, fixed or capped feeSingle submission with defined scope$15,000–$300,000+ depending on pathway
RetainerMonthly fee for ongoing accessCompanies with multiple submissions or ongoing needs$5,000–$25,000/month
HourlyBill for actual hours workedSmall-scope projects, advisory workRates from table above
HybridFixed fee for defined phases + hourly for variable workComplex projects with uncertain scopeVaries

Cost-Saving Strategies

1. Qualify for Small Business Status

If your company has $100 million or less in revenue, the FDA Small Business Determination program reduces the 510(k) user fee from $26,067 to $6,517. Companies with $30 million or less qualify for a first-time PMA fee waiver. This does not reduce consulting fees but significantly lowers total project costs.

2. Use Pre-Submissions Strategically

A well-prepared Q-Submission ($5,000–$15,000 in consultant fees) can save $20,000–$100,000 in remediation costs by catching issues early. The FDA provides written feedback that helps de-risk your submission strategy.

3. Build Internal Capability

For companies planning multiple submissions, investing in an internal regulatory professional (salary $90,000–$180,000/year in the US) can be more cost-effective than outsourcing every project. A hybrid model — internal staff managing day-to-day work with external consultants providing specialized expertise — often provides the best value.

4. Prepare Your Own Documentation

Consultants spend significant time gathering basic information. Providing organized technical files, complete test reports, and well-documented design history files can reduce consulting hours by 20–40%.

5. Bundle Market Submissions

If you're targeting multiple markets, some consulting firms offer multi-market packages at a discount compared to engaging separate firms for each jurisdiction. This works particularly well when the same technical documentation can be adapted for different regulatory formats (e.g., STED for Japan, CSDT for ASEAN).

Frequently Asked Questions

How much does a regulatory consultant cost for a 510(k)?

Total consulting costs for a 510(k) typically range from $17,500 to $50,000 for straightforward submissions and $50,000 to $120,000 for complex ones. This is separate from the FDA user fee ($26,067 standard / $6,517 small business) and testing costs ($20,000–$150,000+).

Which region has the highest regulatory consulting rates?

The United States and Japan have the highest regulatory consulting rates, with Tier 1 consultants charging $375–$450/hr (US) and $360–$430/hr (Japan). Japan's rates are driven by mandatory PMDA consultations and the requirement for all documentation to be in Japanese.

Can I negotiate consulting rates?

Yes, particularly for multi-project engagements. Many firms offer 5–10% discounts for retainer arrangements of 40+ hours per month, and bundled multi-market submissions often receive preferential pricing. However, the quality of the consultant should be your primary consideration — a more expensive but experienced consultant who clears your device on the first submission is cheaper than a cheaper consultant who requires multiple cycles.

How do I know if a consulting rate is fair?

Compare proposals from multiple firms, ensure they specify the tier of consultant working on your project, and evaluate the total project cost (not just hourly rates) against the benchmarks in this guide. Rates significantly below market averages may indicate inexperience or scope underestimation.

Are consulting fees different for startups vs. established companies?

Some firms offer startup-friendly pricing, particularly for early-stage companies. However, the work required is the same regardless of company size. The most common approach is a hybrid model where the firm provides strategic guidance (Tier 1) and the startup's internal team handles documentation under consultant supervision.